Vlad Coric, M.D., is a distinguished figure in the pharmaceutical industry, currently serving as the Chief Executive Officer at BIOHAVEN LTD. Dr. Coric's professional journey is marked by his extensive experience in clinical development and his commitment to advancing treatments for neurological and neuropsychiatric disorders. Before joining BIOHAVEN, he held significant roles at Bristol-Myers Squibb and received his medical degree from Yale University School of Medicine, where he also completed his residency in psychiatry. At BIOHAVEN LTD, Dr. Coric has been instrumental in steering the company towards its mission of developing innovative therapies for patients with debilitating neurological and neuropsychiatric conditions. Under his leadership, BIOHAVEN has made significant strides in its clinical programs, particularly in the development of treatments for Alzheimer's disease, epilepsy, and other serious neurological disorders. His strategic vision and dedication to scientific excellence have been pivotal in forging collaborations with leading research institutions and in advancing the company's pipeline of novel therapeutics. Dr. Coric's achievements extend beyond his role at BIOHAVEN. He has contributed to numerous peer-reviewed publications and has been recognized for his contributions to the field of neuropsychiatry. His leadership style is characterized by a deep understanding of the scientific process combined with a compassionate approach to patient care, making him a respected leader in the biopharmaceutical industry. As CEO, Dr. Coric continues to drive BIOHAVEN's growth and its commitment to improving the lives of patients worldwide.